alanyl-leucyl-alanyl-leucine has been researched along with daunorubicin in 1 studies
*Daunorubicin: A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. [MeSH]
*Daunorubicin: A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. [MeSH]
| Studies (alanyl-leucyl-alanyl-leucine) | Trials (alanyl-leucyl-alanyl-leucine) | Recent Studies (post-2010) (alanyl-leucyl-alanyl-leucine) | Studies (daunorubicin) | Trials (daunorubicin) | Recent Studies (post-2010) (daunorubicin) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 8,239 | 886 | 1,310 |
| Protein | Taxonomy | alanyl-leucyl-alanyl-leucine (IC50) | daunorubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 1.9 | |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.047 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.22 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijsterbosch, MK; Rensen, PC; Rump, ET; Van Berkel, TJ; Versluis, AJ | 1 |
1 other study(ies) available for alanyl-leucyl-alanyl-leucine and daunorubicin
| Article | Year |
|---|---|
Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapy.
Topics: Antibiotics, Antineoplastic; Cholesterol Esters; Cholic Acids; Daunorubicin; Drug Carriers; Emulsions; Humans; Liposomes; Oligopeptides; Prodrugs; Receptors, LDL; Structure-Activity Relationship | 1998 |